Lv6
1980 积分 2022-06-02 加入
949 First-in-human study of the first acid pH-sensitive and recycling CTLA-4 antibody that preserves the immune tolerance checkpoint to avoid immunotherapy-related adverse events in cancer patients
23天前
已完结
471 Pharmacokinetics of first and repeated dosing of non-irAE-inducing anti-CTLA-4 monoclonal antibody ONC-392 in advanced cancer patients
23天前
已完结
471 Pharmacokinetics of first and repeated dosing of non-irAE-inducing anti-CTLA-4 monoclonal antibody ONC-392 in advanced cancer patients
28天前
已完结
949 First-in-human study of the first acid pH-sensitive and recycling CTLA-4 antibody that preserves the immune tolerance checkpoint to avoid immunotherapy-related adverse events in cancer patients
28天前
已关闭
Identification of human brain tumour initiating cells
4个月前
已完结
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
7个月前
已完结
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
7个月前
已完结
Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-Analysis
11个月前
已完结
Homology modeling in drug discovery: current trends and applications
11个月前
已完结
皖公网安备34019202002308
